Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06024564 · ClinicalTrials.gov registry record · NA
Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion
A NA study, sponsored by Third Wave Therapeutics.
- Terminated
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT06024564 is a NA study that was terminated before completion, run by Third Wave Therapeutics. The registered enrollment target is 121 participants.
The verdict
NCT06024564, a NA study, was terminated before completion, sponsored by Third Wave Therapeutics.
- TERMINATED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion
Interventions
- DEVICE Sonu Acoustic Resonance Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06024564
The ClinicalTrials.gov registry entry for NCT06024564 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Third Wave Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sonu Acoustic Resonance Therapy is the first listed.
NCT06024564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06024564 about?
NCT06024564 is a clinical study titled "Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion". Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion
What is the current status of trial NCT06024564?
This trial is currently terminated. It is a NA study. The enrollment target is 121 participants. The study started on 2023-08-08. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT06024564?
The interventions under investigation include: Sonu Acoustic Resonance Therapy (DEVICE).
Who is sponsoring clinical trial NCT06024564?
This trial is sponsored by Third Wave Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.